Incumaker, Inc. (OTC Pink:QMKR) is a diversified holding company whose strategic plan is to acquire interests in young businesses, and provide financing, advice and guidance to assist them in realizing their potential. The company’s wholly owned subsidiary, Eastern Starr Biotech, is pursuing strategic acquisitions in the Cannabis industries. We continue to identify and evaluate other potential acquisitions that we believe will create shareholder value and return.
QMKR Detailed Quote
|Day's Range:||0.09 - 0.15|
|52wk Range:||0.00 - 0.15|
QMKR Recent Headlines
- Joint Press Release of Eastern Starr Biotech, Inc., CEN Biotech, Inc. and Incumaker, Inc. 04/27/2017 02:48 PM[GlobeNewswire] - ATLANTA, April 27, 2017-- Incumaker, Inc., announces that, Eastern Starr Biotech, Inc., and CEN Biotech, Inc. have received inquiries from a few shareholders regarding the status of the merger agreement ...
- Incumaker announces acquisition of CEN Biotech, Inc. by subsidiary, Eastern Starr Biotech, Inc. 04/12/2017 07:16 PM[GlobeNewswire] - ATLANTA, April 12, 2017-- Incumaker, Inc. announced today that its wholly owned subsidiary, Eastern Starr Biotech, Inc., has acquired CEN Biotech, Inc... CEN Biotech, Inc. and its global ventures will ...
- INCUMAKER, INC. Financials 03/29/2017 05:04 PM
- INCUMAKER, INC. Financials 08/05/2016 05:04 PM